Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294018 · ClinicalTrials.gov registry record
Heart Rate Changes Following the Administration of Sugammadex
A clinical trial, sponsored by Joseph D. Tobias.
- Completed
- Registry status
- 276
- Enrollment target
NCT03294018: Completed study, sponsored by Joseph D. Tobias.
NCT03294018 is a clinical trial that has completed, run by Joseph D. Tobias. The registered enrollment target is 276 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03294018 has completed, sponsored by Joseph D. Tobias.
- COMPLETED
- Registry status
- 276 participants
- Enrollment target
Study Summary
This a prospective study when the clinician decides to use sugammadex, heart rate will be recorded every minute for 15 minutes following its administration. If bradycardia occurs and a clinical decision is made to treat it, the medications and doses used will be recorded.
Interventions
- OTHER Recording heart rate changes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2017-09-06 |
| Est. Completion | 2019-01-10 |
What the finished NCT03294018 record still lists
NCT03294018 is an observational study that tracks outcomes without assigning an intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Recording heart rate changes is the first listed.
NCT03294018 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03294018 about?
NCT03294018 is a clinical study titled "Heart Rate Changes Following the Administration of Sugammadex". This a prospective study when the clinician decides to use sugammadex, heart rate will be recorded every minute for 15 minutes following its administration. If bradycardia occurs and a clinical decision is made to treat it, the medications and doses used will be recorded.
What is the current status of trial NCT03294018?
This trial is currently completed. The enrollment target is 276 participants. The study started on 2017-09-06. Estimated completion is 2019-01-10.
What interventions are being tested in trial NCT03294018?
The interventions under investigation include: Recording heart rate changes (OTHER).
Who is sponsoring clinical trial NCT03294018?
This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI